PeptideDB

Inflachromene

CAS No.: 908568-01-4

Inflachromene (ICM) is an inhibitor of HMGB1 and HMGB expression with anti-inflammatory activity.Inflachromene reduces s
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Inflachromene (ICM) is an inhibitor of HMGB1 and HMGB expression with anti-inflammatory activity.Inflachromene reduces seizure severity in a mouse model of epilepsy by inhibiting HMGB1 translocation, inhibits endothelial proliferation through the HMGB1/2-regulated TLR4-NF-κB pathway, and inhibits autophagy by regulating Beclin 1 activity. Inflachromene can be used to study epilepsy.
In vitro 在BV-2微膠細胞中,Inflachromene以劑量依賴的方式高效地阻止LPS誘導的一氧化氮釋放(0.01-100 μM; 24小時),且無任何毒性[1]。LPS刺激後,Inflachromene(1-10 μM)抑制炎症相關基因如Il6、Il1b、Nos2和Tnf的上調[1]。在5 μM濃度下,Inflachromene減少LPS誘導的促炎細胞因子TNF-α的分泌[1]。在微膠質細胞中,Inflachromene(5 μM; 30分鐘)顯著抑制NF-κB的核內轉移和IκB的降解[1]。LPS誘導的微膠質細胞中ERK、JNK和p38 MAPK的磷酸化被Inflachromene(1-10 μM; 30分鐘)抑制[1]。在神經母細胞瘤與初級神經細胞的共培養中,Inflachromene(10 μM; 30分鐘)通過抑制微膠質細胞介導的神經毒性完全防止了細胞死亡[1]。對於神經元的活性,Inflachromene(1-10 μM; 24小時)沒有顯著影響[1]。
In vivo 以剂量依赖的方式 (2-10 mg/kg;每日一次,连续四天),Inflachromene 有效阻断了LPS介导的小胶质细胞激活[1]。在30天的时间里(10 mg/kg;每日一次),Inflachromene 显著减缓了疾病的进展,如EAE临床评分所确定[1]。通过静脉注射(i.v.)以1 mg/kg的剂量给药时,Inflachromene 表现出较长的半衰期(14.1±6.43小时)和中等的稳态体积分布(Vss)(2.02±1.02 L/kg)[2]。口服给药(p.o.)1 mg/kg剂量时,Inflachromene 展现出高口服生物利用度(94%)和最大血浆浓度(Cmax)(0.59±0.16 g/mL)[2]。
Synonyms ICM
molecular weight 377.39
Molecular formula C21H19N3O4
CAS 908568-01-4
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 80 mg/mL (211.98 mM), Sonication is recommended.
References 1. Lee S, et, al. A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation. Nat Chem Biol. 2014 Dec; 10(12): 1055-60. 2. Lee HH, et al. A validated UPLC-MS/MS method for pharmacokinetic study of inflachromene, a novel microglia inhibitor. J Pharm Biomed Anal. 2019 Mar 20; 166: 183-188. 3. Cho W, Koo JY, Park Y, Oh K, Lee S, Song JS, Bae MA, Lim D, Lee DS, Park SB. Treatment of Sepsis Pathogenesis with High Mobility Group Box Protein 1-Regulating Anti-inflammatory Agents. J Med Chem. 2017 Jan 12;60(1):170-179. doi: 10.1021/acs.jmedchem.6b00954. Epub 2016 Dec 21. PubMed PMID: 28001381. 4. Block ML. Neuroinflammation: modulating mighty microglia. Nat Chem Biol. 2014 Dec;10(12):988-9. doi: 10.1038/nchembio.1691. PubMed PMID: 25393492.
Citations 1. Jiang J, Shao X, Liu W, et al.The mechano-chemical circuit in fibroblasts and dendritic cells drives basal cell proliferation in psoriasis.Cell Reports.2024, 43(7): 114513.